Tumor necrosis factor (TNF) and a TNF-mimetic peptide modulate the granulomatous response to Mycobacterium bovis BCG infection in vivo

Infection and Immunity

Volumn 67, Issue 10, 1999, Pages 5473-5476

  Roach, D R ^a   Briscoe, H ^a   Baumgart, K ^a   Rathjen, D A ^b   Britton, W J ^a  

^a CENTENARY INSTITUTE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CELL COMPOSITION; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GRANULOMA; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0032831835     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.10.5473-5476.1999     Document Type: Article

References (21)

1. Adams, L. B., C. M. Mason, J. K. Kolls, D. Scollard, J. L. Krahenbuhl, and S. Nelson. 1995. Exacerbation of acute and chronic murine tuberculosis by administration of a tumour necrosis factor receptor-expressing adenovirus. J. Infect. Dis. 171:400-405.
2. Bean, A. G. D., D. R. Roach, H. Briscoe, M. P. France, H. Korner, J. D. Sedgwick, and W. J. Britton. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection which is not compensated by lymphotoxin. J. Immunol. 162:3504-3511.
3. Britton, W. J., N. Meadows, D. A. Rathjen, O. R. Roach, and H. Briscoe. 1998. A tumor necrosis factor mimetic peptide activates a murine macrophage cell line to inhibit mycobacterial growth in a nitric oxide-dependent fashion. Infect. Immun. 66:2122-2127.
4. Chan, J., Y. Xing, R. S. Magliozzo, and B. R. Bloom. 1992 Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122.
5. Collins, F. M., and V. Montalbine. 1976. Distribution of in vivo grown mycobacteria in the organs of intravenously infected mice. Am. Rev. Respir. Dis. 113:281-286.
6. Cooper, A. M., D. K. Dalton, T. A. Stewart, J. P. Griffin, D. G. Russell, and I. M. Orme. 1993. Disseminated tuberculosis in interferon-γ gene disrupted mice. J. Exp. Med. 178:2243-2247.
7. Dannenberg, A. M. 1991. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol. Today 12:228-233.
8. Denis, M. 1991. Involvement of cytokines in determining resistance and acquired immunity in murine tuberculosis. J. Leukoc. Biol. 50:495-501.
9. Desiderio, J. V., P. A. Kiener, P.-F. Lin, and G. A. Warr. 1989. Protection of mice against Listeria monocytogenes infection by recombinant tumor necrosis factor alpha. Infect. Immun. 57:1615-1617.
10. Flesch, I. E. A., and S. H. E. Kaufmann. 1990. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675-2677.
11. Flynn, J. L., J. Chan, K. J. Triebold, D. K. Dalton, T. A. Stewart, and B. R. Bloom. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254.
12. Flynn, J. L., M. M. Goldstein, J. Chan, K. J. Triebold, K. Pfeffer, C. J. Lowenstein, R. Shreiber, T. W. Mak, and B. R. Bloom. 1995. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
13. Kaufmann, S. H. E. 1993. Immunity to intracellular mycobacteria. Annu. Rev. Immunol. 11:129-163.
14. Kindler, V., A. P. Sappino, G. E. Grau, P.-F. Piguet, and P. Vassalli. 1989. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell 56:731-740.
15. Kumaratilake, L. M., D. A. Rathjen, P. Mack, F. Widmer, V. Prasertsiriroj, and A. Ferrante. 1995. A synthetic tumor necrosis factor-α agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice. J. Clin. Investig. 95:2315-2323.
16. Laichalk, L. L., K. A. Backnell, G. B. Huffnagle, J. M. Wilkowski, T. A. Moore, R. J. Romanelli, and J. J. Standiford. 1998. Intrapulmonary delivery of tumor necrosis factor agonist peptide augments host defense in murine gram-negative bacterial pneumonia. Infect. Immun. 66:2822-2826.
17. Mehrad, B., R. M. Strieter, and T. J. Stadiford. 1999. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J. Immunol. 136: 1633-1640.
18. Orme, I. M. 1996. The immunopathogenesis of tuberculosis: a new working hypothesis. Trends Microbiol. 6:94-97.
19. Rathjen, D. A., A. Ferrante, and R. Aston. 1993. Differential effects of small tumour necrosis factor a peptides on tumour cytotoxicity, neutrophil activation and endothelial cell procoagulant. Immunology 80:293-299.
20. Rathjen, D. A. Unpublished observations.
21. Sheffield, E. A. 1990. The granulomatous inflammatory response. J. Pathol. 160:1-2.